Skip to content

Geron GERN Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Immunome logo
ImmunomeIMNM
$0-100%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$862K-76.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M-25.0%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.18M+23.6%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1.03M-55.2%

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-8.6%
Enterprise value$973.78M-6.2%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's accretion (amortization) of discounts and premiums, investments?
Geron (GERN) reported accretion (amortization) of discounts and premiums, investments of $1.07M in Q1 2026.
How has Geron's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Geron's accretion (amortization) of discounts and premiums, investments decreased by 51.6% year-over-year, from $2.21M to $1.07M.
What is the long-term trend for Geron's accretion (amortization) of discounts and premiums, investments?
Over 4 years (2021 to 2025), Geron's accretion (amortization) of discounts and premiums, investments has grown at a 48.5% compound annual growth rate (CAGR), from -$1.42M to $6.92M.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the non-cash adjustment to interest income or expense resulting from the amortization of premiums or accretion of discounts on investment securities held by the company. It reflects the gradual adjustment of the carrying value of investments toward their par value over time. Investors use this to understand the non-cash impact of investment portfolio management on reported net income.